PARIS--(BUSINESS WIRE)--EOS imaging (Paris:EOSI) (Euronext, FR0011191766 – EOSI), the pioneer in 2D/3D orthopaedic medical imaging, today announces its consolidated revenue for the fourth quarter and full year ended December 31, 2015.
In 2015, EOS imaging recorded revenue of €2.21 million in Asia-Pacific, a decrease of 60%, following a strong entry into this market in 2014. In the second half of 2015, the Company experienced disruption in Japan, a key market, due to a transition with its commercial organization, which the Company expects will have a positive impact on results in Japan in 2016.
